Treating PSCK9 disorders with CRISPR tech: “Verve-101, is a lipid nanoparticle formulation of mRNA to code for the needed CRISPR enzymes and a guide RNA to send them to the right spot on the genome.” Posted on July 16, 2022 by jgordon Link. First human trial.